Q1 results
Vedanta Q1 net profit rises 37% to Rs 3,606 cr, demerger plan on track
Tata Chemicals Q1 profit down 72% to Rs 150 cr on lower income, higher expenses
Acquisition of BSV to aid future growth of Mankind Pharma, says Vice Chairman Juneja
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg)
/newsdrum-in/media/media_files/Tcq5KUowbHyjdW5O6PS7.jpg)
/newsdrum-in/media/media_files/dd1oqCkaCYNMCaPKWLLO.jpg)
/newsdrum-in/media/media_files/p4rVTCpFjKENOxEmMtJa.jpg)
/newsdrum-in/media/media_files/kdKAS6q3JN66XyvTEHVQ.jpg)
/newsdrum-in/media/media_files/2Gq5zzPQK4O2VuVBVivF.jpg)
/newsdrum-in/media/media_files/BMM92EqeadtZDcCqQZOj.jpg)
/newsdrum-in/media/media_files/EoYj0U4Nqiof4eZSmhtg.jpg)
/newsdrum-in/media/media_files/3bR0covULUm5mzNBmDg4.jpg)
/newsdrum-in/media/media_files/ialKBh23HJgfXBExhaPY.jpg)
/newsdrum-in/media/media_files/2679NVhwK5euCeLHMyb5.jpg)
